Related Experiment Video
Updated: Sep 9, 2025

08:07
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
Published on: April 5, 2024
986
Decoding adenomyosis pathogenesis using an assembloid model
Yiliang Xu1,2, Tao Cheng3, Jianzhang Wang4
1Key Laboratory of Animal Bioengineering and Disease Prevention of Shandong Province, College of Animal Science and Technology, Shandong Agricultural University, Tai'an, 271018, China.
Science China. Life Sciences
|September 1, 2025
Summary
Researchers developed a novel endometrial assembloid model to study adenomyosis. This model mimics menstrual cycle changes and reveals aberrant WNT signaling in adenomyosis, suggesting a new therapeutic target for this challenging gynecological disorder.
Area of Science:
- Gynecology
- Cell Biology
- Tissue Engineering
Background:
- Adenomyosis research is hindered by the lack of accurate in vitro models.
- Existing models do not fully replicate endometrial tissue dynamics throughout the menstrual cycle.
Purpose of the Study:
- To establish a novel endometrial assembloid model for studying adenomyosis.
- To investigate the cellular and molecular mechanisms underlying adenomyosis pathogenesis.
Main Methods:
- Development of a 3D endometrial assembloid model.
- Single-cell transcriptomics to analyze cellular changes.
- Analysis of stromal-epithelial signaling pathways.
Main Results:
- The assembloid model accurately mimics cycle-dependent endometrial responses and adenomyosis hallmarks.
- Ectopic epithelial cells exhibit a luminal-dominant, glandular-deficient profile during the secretory phase.
- Stromal reorganization involves loss of BMP4+ cells and gain of CRYAB+IL15+ cells, impairing BMP signaling and activating WNT signaling.
- Ectopic cells show increased immunity and angiogenesis.
Conclusions:
- The endometrial assembloid platform provides a physiologically relevant model for adenomyosis research.
- Aberrant WNT signaling is implicated in adenomyosis pathogenesis and represents a potential therapeutic target.
- This model offers new avenues for developing mechanism-driven treatment strategies for adenomyosis.

